| ACE inhibitor | Angiotensin-Converting Enzyme Inhibitor |
| FDA | Food and Drug Administration |
| EMA | European Medicines Agency |
| WHO | World Health Organization |
| BN | Buccal Nitroglycerin |
| SLGTN | Sublingual Glyceryl Trinitrate |
| BGTN | Buccal Glyceryl Trinitrate |
| NTG | Nitroglycerin |
| TRH | Thyrotropin-Releasing Hormone |
| GLP-1 | Glucagon-Like Peptide-1 |
| FITC-dextran | Fluorescein Isothiocyanate-Dextran |
| ISMO | Isosorbide Mononitrate |
| APIs | Active Pharmaceutical Ingredients |
| Tmax | Time to Maximum Plasma Concentration |
| AUC | Area Under the Curve |
| LEV-INS | Liposome-Encapsulated Insulin |
| SLIT | Sublingual Immunotherapy |
| BEMA® | BioErodible MucoAdhesive |
| REMS | Risk Evaluation and Mitigation Strategy |
| PEG | Polyethylene Glycol |
| ALKS 5461 | (No abbreviation; this is a drug code for a specific investigational medication) |
| VLPs | Virus-Like Particles |
| CTB | Cholera Toxin B |
| APC | Antigen-Presenting Cells |
| CYP3A4 | Cytochrome P450 3A4 |
| mRNA | Messenger Ribonucleic Acid |
| RX | Prescription only |
| OTC | Over the counter |
| DISCN | Discontinued |